Surgical outcomes and prognostic factors for T2 gallbladder cancer following surgical resection
- PMID: 20033339
- DOI: 10.1007/s11605-009-1132-z
Surgical outcomes and prognostic factors for T2 gallbladder cancer following surgical resection
Abstract
Background: Depth of tumor invasion is an important prognostic factor for gallbladder cancer. The aim of this study was to investigate the clinicopathological prognostic factors of T2 gallbladder cancer.
Methods: We retrospectively reviewed the clinicopathological data and survival for 83 patients with T2 gallbladder cancers who underwent surgical resection between January 1995 and December 2007.
Results: The overall survival rates were 48.9% at 3 years and 29.3% at 5 years. Univariate analysis revealed that R0 resection (P < 0.001), extended surgery (P = 0.028), lymph node dissection (P = 0.024), non-infiltrative tumors (P = 0.001), well differentiation (P = 0.001), absence of lymphatic (P = 0.025), perineural (P = 0.001), and vascular (P = 0.025) invasion, absence of lymph node metastasis (P = 0.001), negative resection margin (P = 0.016), and stage (P = 0.002) were significantly better predictors for survival. A significant difference in survival between Rx and R1 was not found. R0 resection, lymph node dissection, well differentiation, and absence of perineural and vascular invasion were significantly independent prognostic factors for overall survival. Recurrence occurred in 48 patients (57.8%). Age older than 65 years, R0 resection, non-infiltrative tumors, and good differentiation were significant independent predictors of disease-free survival by multivariate analysis.
Conclusions: For T2 tumors, radical surgery including lymph node dissection should be performed to achieve R0 resection. Tumors with infiltrative types and suspicious lymph node metastasis in the intraoperative findings were candidates for aggressive surgical management to improve patient survival.
Similar articles
-
Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.J Am Coll Surg. 2001 May;192(5):600-7. doi: 10.1016/s1072-7515(01)00814-6. J Am Coll Surg. 2001. PMID: 11333097
-
Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.Surgery. 2017 Sep;162(3):515-524. doi: 10.1016/j.surg.2017.05.004. Epub 2017 Jun 16. Surgery. 2017. PMID: 28629653
-
Fourteen year surgical experience of gallbladder cancer: validity of curative resection affecting survival.Hepatogastroenterology. 2012 Jan-Feb;59(113):36-41. doi: 10.5754/hge10297. Hepatogastroenterology. 2012. PMID: 22251521
-
Radical cholecystectomy without liver resection for peritoneal side early incidental gallbladder cancer.World J Gastroenterol. 2024 Aug 28;30(32):3739-3742. doi: 10.3748/wjg.v30.i32.3739. World J Gastroenterol. 2024. PMID: 39221070 Free PMC article. Review.
-
Gallbladder cancer.Cancer Treat Res. 2001;109:145-55. doi: 10.1007/978-1-4757-3371-6_8. Cancer Treat Res. 2001. PMID: 11775433 Review.
Cited by
-
Anatomic patterns of recurrence in biliary tract cancers: does primary tumor site matter?J Gastrointest Oncol. 2022 Jun;13(3):1413-1422. doi: 10.21037/jgo-21-868. J Gastrointest Oncol. 2022. PMID: 35837169 Free PMC article.
-
Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study.Ann Surg. 2015 Apr;261(4):733-9. doi: 10.1097/SLA.0000000000000728. Ann Surg. 2015. PMID: 24854451 Free PMC article.
-
Progress in gallbladder cancer with lymph node metastasis.Front Oncol. 2022 Aug 22;12:966835. doi: 10.3389/fonc.2022.966835. eCollection 2022. Front Oncol. 2022. PMID: 36072797 Free PMC article. Review.
-
Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma.Ann Surg Oncol. 2016 Dec;23(13):4401-4409. doi: 10.1245/s10434-016-5470-2. Epub 2016 Aug 5. Ann Surg Oncol. 2016. PMID: 27495279 Free PMC article.
-
The optimal surgical resection approach for T2 gallbladder carcinoma: evaluating the role of surgical extent according to the tumor location.Ann Surg Treat Res. 2018 Mar;94(3):135-141. doi: 10.4174/astr.2018.94.3.135. Epub 2018 Feb 28. Ann Surg Treat Res. 2018. PMID: 29520347 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical